Financial results - NUCLEUS MED S.R.L.

Financial Summary - Nucleus Med S.r.l.
Unique identification code: 35251188
Registration number: J08/1915/2015
Nace: 8690
Sales - Ron
51.288
Net Profit - Ron
-2.126
Employee
1
The most important financial indicators for the company Nucleus Med S.r.l. - Unique Identification Number 35251188: sales in 2023 was 51.288 euro, registering a net profit of -2.126 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Alte activitati referitoare la sanatatea umana having the NACE code 8690.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Nucleus Med S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - 821 6.369 24.877 37.578 36.340 40.011 67.818 61.619 51.288
Total Income - EUR - 821 6.369 24.878 47.923 54.057 46.044 87.444 62.073 89.806
Total Expenses - EUR - 1.166 7.325 11.860 37.049 47.259 49.623 56.442 62.490 91.932
Gross Profit/Loss - EUR - -345 -956 13.018 10.874 6.798 -3.579 31.001 -418 -2.126
Net Profit/Loss - EUR - -370 -1.147 12.272 10.042 6.179 -3.846 29.085 -1.684 -2.126
Employees - 0 0 1 1 1 2 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -16.5%, from 61.619 euro in the year 2022, to 51.288 euro in 2023.

Check the financial reports for the company - Nucleus Med S.r.l.

Rating financiar

Financial Rating -
Nucleus Med S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Nucleus Med S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Nucleus Med S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Nucleus Med S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Nucleus Med S.r.l. - CUI 35251188

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - 6.074 4.509 2.955 4.733 22.210 12.787 11.364 8.029 32.491
Current Assets - 60 1.745 8.595 17.434 24.742 10.642 41.173 42.831 16.452
Inventories - 0 0 0 200 0 0 0 0 0
Receivables - 0 1.559 3.859 1.747 3.121 726 9 2 41
Cash - 60 186 4.735 15.487 21.621 9.917 41.165 42.829 16.411
Shareholders Funds - -325 -1.469 10.828 20.671 26.450 22.103 50.697 49.171 46.895
Social Capital - 45 45 44 43 42 41 40 41 40
Debts - 6.459 7.723 722 1.496 20.502 1.326 1.840 1.689 2.047
Income in Advance - 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8690 - 8690"
CAEN Financial Year 8690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 16.452 euro in 2023 which includes Inventories of 0 euro, Receivables of 41 euro and cash availability of 16.411 euro.
The company's Equity was valued at 46.895 euro, while total Liabilities amounted to 2.047 euro. Equity decreased by -2.126 euro, from 49.171 euro in 2022, to 46.895 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Nucleus Med S.r.l.

Comments - Nucleus Med S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.